These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17426229)

  • 21. Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study.
    Miyashita N; Fukano H; Mouri K; Fukuda M; Yoshida K; Kobashi Y; Niki Y; Oka M
    J Med Microbiol; 2005 Apr; 54(Pt 4):395-400. PubMed ID: 15770027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of new therapies for severe community-acquired pneumonia.
    Restrepo MI; Anzueto A
    Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pay attention to new evolution trends in the etiology of community-acquired pneumonia in adults].
    He LX
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jun; 47(6):576-581. PubMed ID: 38858211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community-acquired pneumonia in HIV-infected children: a global perspective.
    Gray DM; Zar HJ
    Curr Opin Pulm Med; 2010 May; 16(3):208-16. PubMed ID: 20375782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community-acquired pneumonia.
    Remington LT; Sligl WI
    Curr Opin Pulm Med; 2014 May; 20(3):215-24. PubMed ID: 24614242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Community-Acquired Bacterial Pneumonia-Changing Epidemiology, Resistance Patterns, and Newer Antibiotics: Spotlight on Delafloxacin.
    Sharma R; Sandrock CE; Meehan J; Theriault N
    Clin Drug Investig; 2020 Oct; 40(10):947-960. PubMed ID: 32889706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The science of selecting antimicrobials for community-acquired pneumonia (CAP).
    File TM
    J Manag Care Pharm; 2009 Mar; 15(2 Suppl):S5-11. PubMed ID: 19236135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Etiology of community acquired pneumonia in inpatients children. Uruguay 1998-2004].
    Ferrari C AM; Pirez G MC; Martínez A A; Algorta R G; Chamorro V F; Guala B MJ; Zabala Ch C; Giachetto L G; Montano L A
    Rev Chilena Infectol; 2007 Feb; 24(1):40-7. PubMed ID: 17369969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multistep antimicrobial stewardship intervention on antibiotic prescriptions and treatment duration in children with pneumonia.
    Rossin S; Barbieri E; Cantarutti A; Martinolli F; Giaquinto C; Da Dalt L; Doná D
    PLoS One; 2021; 16(10):e0257993. PubMed ID: 34705849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community-acquired pneumonia team decreases length of stay in hospitalized, low-risk patients with pneumonia.
    Marcos PJ; Restrepo MI; Sanjuàn P; Ferreira-Gonzalez L; Verea-Hernando H
    Hosp Pract (1995); 2013 Aug; 41(3):7-14. PubMed ID: 23948616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community acquired bacterial pneumonia.
    Anevlavis S; Bouros D
    Expert Opin Pharmacother; 2010 Feb; 11(3):361-74. PubMed ID: 20085502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection.
    Yanagihara K; Izumikawa K; Higa F; Tateyama M; Tokimatsu I; Hiramatsu K; Fujita J; Kadota J; Kohno S
    Intern Med; 2009; 48(7):527-35. PubMed ID: 19336954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved management of community-acquired pneumonia in the emergency department.
    Julián-Jiménez A; Palomo de los Reyes MJ; Parejo Miguez R; Laín-Terés N; Cuena-Boy R; Lozano-Ancín A
    Arch Bronconeumol; 2013 Jun; 49(6):230-40. PubMed ID: 23477946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outpatient management of community-acquired pneumonia.
    Froes F; Pereira JG; Póvoa P
    Curr Opin Pulm Med; 2019 May; 25(3):249-256. PubMed ID: 30585861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Community-acquired pneumonia].
    Blanquer J; Sanz F
    Arch Bronconeumol; 2010 Oct; 46 Suppl 7():26-30. PubMed ID: 21316547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. International guidelines for the treatment of community-acquired pneumonia in adults: the role of macrolides.
    File TM; Tan JS
    Drugs; 2003; 63(2):181-205. PubMed ID: 12515565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community-acquired pneumonia.
    Lynch JP; Martinez FJ
    Curr Opin Pulm Med; 1998 May; 4(3):162-72. PubMed ID: 9675519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severity assessment in community-acquired pneumonia.
    Ewig S; Schäfer H; Torres A
    Eur Respir J; 2000 Dec; 16(6):1193-201. PubMed ID: 11292126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.
    Niven DJ; Laupland KB
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):69-81. PubMed ID: 19622058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hospitalist perspective on treatment of community-acquired bacterial pneumonia.
    Amin AN; Cerceo EA; Deitelzweig SB; Pile JC; Rosenberg DJ; Sherman BM
    Postgrad Med; 2014 Mar; 126(2):18-29. PubMed ID: 24685965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.